July 10, 2024 BHR Newsletter 1. Eli Lilly plans for $3.2B purchase Full story 2. Insurers brought in $50B through 'questionable' Medicare Advantage coding: WSJ Full story 3. Ozempic vs. Mounjaro: Which fared better in 1st large study Full story…
Life Sciences
July 3, 2024 BHR Newsletter 1. Biden, Sanders to Ozempic maker: 'Stop ripping off' Americans Full story 2. Chevron ruling may hinder drug development, experts say Full story 3. FTC probes Teva over drug patents Full story 4. Health systems…
June 26, 2024 BHR Newsletter 1. J&J acquires immune disease biologics company for $850M Full story 2. Teva launches first generic GLP-1 Full story 3. Eli Lilly hits phony drugmakers with 6 more lawsuits Full story 4. Added ASC-covered procedures…
June 12, 2024 BHR Newsletter 1. Sanders calls vote to subpoena Novo Nordisk president Full story 2. Proposed legislation hopes to remove healthcare 'corporate greed': 7 things to know Full story 3. FDA panel votes in favor of Alzheimer's drug…
June 5, 2024 BHR Newsletter 1. Novartis sues Maryland over law prohibiting restrictions on 340B drugs Full story 2. Fortune 500's top 25 healthcare companies Full story 3. Sagent recalls 2 lots of cancer drug Full story 4. It's time…
May 29, 2024 BHR Newsletter 1. J&J to buy skin drug for $1.25B Full story 2. 12 health systems moving to Epic Full story 3. Pfizer recalls 5 drug lots for potential packaging error Full story 4. 4 systems' nurse…
May 22, 2024 BHR Newsletter 1. AstraZeneca to pay $107.5M for cancer drug patent infringement Full story 2. 10 highest-paid healthcare CEOs Full story 3. FDA approves 2 Eylea biosimilars Full story 4. 600+ infusion centers are increasing volumes with…
May 16, 2024 BHR Newsletter 1. About 200 exposed to measles at UC Davis Health, officials say Full story 2. Intermountain expands central lab to reduce testing costs Full story 3. Merck halts research on combo drug for skin cancer…
May 8, 2024 BHR Newsletter 1. Child dies in gene therapy trial; Pfizer pauses study Full story 2. Steward plans sale of all hospitals, reports $9B in debt Full story 3. Biotech company lays off 49% of workforce Full story…
May 1, 2024 BHR Newsletter 1. J&J to resolve most cancer talc claims for $6.5B Full story 2. Walmart Health to close all 51 health clinics, virtual care Full story 3. 11 drugs now in shortage Full story 4. Thousands…